US equities |
NVDA $236.88 ▲+1.25% SPCX $165.47 ▲+4.09% MU $1,066.82 ▼-0.75% TSLA $378.61 ▲+2.16% MSFT $526.41 ▲+1.71% INTC $117.17 ▼-1.81% SNDK $1,728.44 ▲+0.49% META $741.50 ▲+1.84%
FinancialContent

Articles published by Acadia Pharmaceuticals, Inc.

News headline image
Acadia Pharmaceuticals Presents DAYBUE™ (trofinetide) Real-World Evidence and Additional Data in Rett Syndrome at the 2024 International Rett Syndrome Foundation (IRSF) Annual Scientific Meeting
From Acadia Pharmaceuticals, Inc.
Via Business Wire
Tickers ACAD